For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient to help them reach their target cholesterol levels.

For these patients, a new experimental pill could offer some hope.

Phase 3 trial data found that people who took the investigational drug enlicitide with their routine cholesterol-lowering regimen, like statins, saw up to a 60 per cent reduction in their LDL or "bad" cholesterol after 24 weeks of daily treatment, according to a news release about the results. 

That was in comparison with people who took a placebo along with their routine cholesterol-lowering medications.

All study participants had high levels of LDL cholesterol and a history of either a major cardiovascular disease event, or they were at an i

See Full Page